Abstract
Targeting apoptosis is a principal strategy in the design of anticancer drugs. In recent years, non-platinum-based scaffolds have been exploited as viable candidates for the exploitation of anticancer agents with potentially lower toxicity than the widely used cisplatin analogues. This review highlights the latest advances in developing iridium(III) complexes as anticancer agents that act particularly via targeting apoptotic cell death in cancer cells.
Original language | English |
---|---|
Journal | Molecules |
Volume | 24 |
Issue number | 15 |
DOIs | |
Publication status | Published - 28 Jul 2019 |
Scopus Subject Areas
- Analytical Chemistry
- Chemistry (miscellaneous)
- Molecular Medicine
- Pharmaceutical Science
- Drug Discovery
- Physical and Theoretical Chemistry
- Organic Chemistry
User-Defined Keywords
- apoptosis
- cancer
- iridium(III) complex
- mitochondria